...its good to see Merck backing their [CRME] oral drug hopefully that means it gets to market (sooner)! Oral Vernakalant finally moving to phase III: http://finance.yahoo.com/news/Cardiome-Provides-Update-for-prnews-3077502994.html?x=0&.v=3